VEEA INC. (NASDAQ: VEEA) filed an S-3 shelf registration statement with the SEC, establishing a $75 million mixed-securities facility covering common stock, preferred stock, debt securities, warrants, rights, and units. No selling stockholders are named and no specific share count is registered, meaning the filing does not authorize immediate resale dilution.

However, the shelf itself is constrained by the SEC's "baby shelf" rule. Under General Instruction I.B.6, issuers with a public float below $75 million may only sell up to one-third of their non-affiliate public float in any rolling 12-month period. With Veea's non-affiliate float at roughly $20.5 million and shares trading at approximately $0.31, that cap limits primary issuance to about $6.8 million per year — a fraction of the $75 million headline figure.

The Convertible Overhang

The more structurally significant dilution factor sits outside the new shelf entirely. Veea has two series of convertible preferred stock already outstanding:

• Series A-1 preferred, convertible into common at $0.31 per share — precisely at the recent market price.
• Series A preferred, convertible at $0.503 per share, modestly above market.

Together, these preferred series represent more than 55 million potential common shares. Set against the current 55.1 million common shares outstanding, full conversion would approximately double the share count. Because the Series A-1 conversion price sits at the current trading level, there is no price buffer between the market and the point at which those shares could enter the float.

Variable-Price and Anti-Dilution Features

The filing's red flags include variable-price conversion mechanics and weighted-average anti-dilution provisions. These features mean that if Veea issues new equity at prices below existing conversion thresholds — whether through the shelf or otherwise — the preferred conversion prices could adjust downward, increasing the number of common shares issuable upon conversion. Cashless exercise provisions further indicate that some instruments may convert without generating cash proceeds for the company, adding shares to the float without corresponding capital inflow.

Structural Takeaway

The $75 million shelf headline overstates the company's near-term issuance capacity due to baby-shelf constraints. The operative dilution variable is the convertible preferred overhang: 55 million-plus shares convertible at or near market price, equipped with anti-dilution protections that could ratchet conversion ratios higher if future equity issuances occur at discounted prices. Any primary offering under the new shelf, even a modest one within the $6.8 million annual cap, could trigger those adjustments and compound the dilutive effect beyond the shares directly issued.